Using Fidelity’s fundamental analysis tool, I looked at the top 100 companies and found which were undervalued and more…

Fidelity's fundamental analysis uses S&P global market intelligence and rates companies based on four factors:

Value, Quality, Growth and Financial Health

I started with just looking at the most undervalued companies of he top 100 largest.

The top 10 in no particular order:

NovoNordisk

Bristol Myers Squibb

Sanofi

American Express

Merck

Roche

Abbvie

Novartis

Pfizer

AstraZeneca

______________________

Then I looked at the combined score, adding quality, growth and financial health to valuation.

The top 10:

Visa

UNH

NovoNordisk

Cisco

Novartis

AstraZeneca

Accenture

Sanofi

BMS

Mastercard

​